Tao Su

15.4k citations
125 papers · 3.6k indexed · h-index 35

Tao Su

121 papers receiving 3.6k citations

Peers

Tao Su
Comparison fields: 5 of 120
  • Cancer Research 441
  • Biochemistry 174
  • Pharmacology 476
  • Pharmacology 236
  • Molecular Biology 1.7k
Replace Kang‐Beom Kwon with:
Kang‐Beom Kwon South Korea
Rajarajan A. Thandavarayan United States
Jeong‐Hyung Lee South Korea
Pil‐Hoon Park South Korea
Jong‐Wook Park South Korea
Shousong Cao United States
Dong Ju Son South Korea
Hong‐Seob So South Korea
Sung‐Hoon Kim South Korea
Wahn Soo Choi South Korea
Tao Su relative to Kang‐Beom Kwon South Korea Kang‐Beom Kwon's profile →
Citations per field
00.5×2.8×
Kang‐Beom Kwon · 1×
Citations per year

Countries citing papers authored by Tao Su

Since Specialization
Citations

This map shows the geographic impact of Tao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Su more than expected).

Fields of papers citing papers by Tao Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Su. The network helps show where Tao Su may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tao Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tao Su Line = papers co-authored together Tao Su links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20253
3 20246
4 20230
5 202312
6 20235
7 20223
8 20223
9 201911
10 201717
11 201617
12 201623
13 201448
14 201435
15 20144
16 201067
17 200933
18
Obtainment and Characterization of The Evolved Enzymes From Arabidopsis thaliana Glutathione S-Transferase Zeta Class
20081
19 200017
20 19514

About Tao Su

Tao Su is a scholar working on Complementary and alternative medicine, Pharmacology and Biochemistry, having authored 125 papers that have together received 3.6k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (11 papers), Cytokine Signaling Pathways and Interactions (10 papers), Natural product bioactivities and synthesis (10 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers), Apelin-related biomedical research (6 papers), Adipose Tissue and Metabolism (6 papers), Cancer-related molecular mechanisms research (6 papers) and Phytochemistry and Biological Activities (6 papers). The work is most often cited by research in Cancer Research (441 citations), Biochemistry (174 citations) and Pharmacology (476 citations). Tao Su has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Hiu Yee Kwan, Zhi‐Ling Yu, Keith E. Mostov, Anfernee Kai‐Wing Tse, Martin ter Beest, Xiu‐Qiong Fu, Huihui Cao, Brian Chi‐Yan Cheng, Mark C. Gillies and Hua Yu. Their work appears in journals such as Scientific Reports, Journal of Ethnopharmacology, Oncotarget, Phytomedicine and Acta Biochimica et Biophysica Sinica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026